Global DNA Repair Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201030352 | Category: Pharma & Healthcare | Pages: 112 | Format: PDF | Published Date: October 04,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The DNA Repair Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global DNA Repair Drugs market size is estimated to be worth US$ 610.8 million in 2021 and is forecast to a readjusted size of USD 1901.1 million by 2028 with a CAGR of 17.6% during review period. Oncological accounting for % of the DNA Repair Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While PARP Inhibitors segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of DNA Repair Drugs include 4SC AG, ARCAGY/ GINECO GROUP, Bristol Myers Squibb, British Columbia Cancer Agency, and Cambridge University Hospitals NHS Foundation Trust, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
DNA Repair Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    PARP Inhibitors
    Other
Market segment by Application can be divided into
    Oncological
    Stroke
The key market players for global DNA Repair Drugs market are listed below:
    4SC AG
    ARCAGY/ GINECO GROUP
    Bristol Myers Squibb
    British Columbia Cancer Agency
    Cambridge University Hospitals NHS Foundation Trust
    Genentech
    Georgetown University
    German Breast Group
    GlaxoSmithKline
    Jiangsu Hengrui Medicine
    Johnson & Johnson
    Jonsson Comprehensive Cancer Center
    Karyopharm Therapeutics
    KuDOS Pharmaceuticals
    National Health Service
    National Institutes of Health
    Tesaro
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe DNA Repair Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of DNA Repair Drugs, with price, sales, revenue and global market share of DNA Repair Drugs from 2019 to 2022.
Chapter 3, the DNA Repair Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DNA Repair Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and DNA Repair Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of DNA Repair Drugs.
Chapter 13, 14, and 15, to describe DNA Repair Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 DNA Repair Drugs Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global DNA Repair Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 PARP Inhibitors
        1.2.3 Other
    1.3 Market Analysis by Application
        1.3.1 Overview: Global DNA Repair Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Oncological
        1.3.3 Stroke
    1.4 Global DNA Repair Drugs Market Size & Forecast
        1.4.1 Global DNA Repair Drugs Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global DNA Repair Drugs Sales in Volume (2017-2028)
        1.4.3 Global DNA Repair Drugs Price (2017-2028) 
    1.5 Global DNA Repair Drugs Production Capacity Analysis
        1.5.1 Global DNA Repair Drugs Total Production Capacity (2017-2028)
        1.5.2 Global DNA Repair Drugs Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 DNA Repair Drugs Market Drivers
        1.6.2 DNA Repair Drugs Market Restraints
        1.6.3 DNA Repair Drugs Trends Analysis
2 Manufacturers Profiles
    2.1 4SC AG
        2.1.1 4SC AG Details
        2.1.2 4SC AG Major Business
        2.1.3 4SC AG DNA Repair Drugs Product and Services
        2.1.4 4SC AG DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 ARCAGY/ GINECO GROUP
        2.2.1 ARCAGY/ GINECO GROUP Details
        2.2.2 ARCAGY/ GINECO GROUP Major Business
        2.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Product and Services
        2.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Bristol Myers Squibb
        2.3.1 Bristol Myers Squibb Details
        2.3.2 Bristol Myers Squibb Major Business
        2.3.3 Bristol Myers Squibb DNA Repair Drugs Product and Services
        2.3.4 Bristol Myers Squibb DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 British Columbia Cancer Agency
        2.4.1 British Columbia Cancer Agency Details
        2.4.2 British Columbia Cancer Agency Major Business
        2.4.3 British Columbia Cancer Agency DNA Repair Drugs Product and Services
        2.4.4 British Columbia Cancer Agency DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Cambridge University Hospitals NHS Foundation Trust
        2.5.1 Cambridge University Hospitals NHS Foundation Trust Details
        2.5.2 Cambridge University Hospitals NHS Foundation Trust Major Business
        2.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product and Services
        2.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Genentech
        2.6.1 Genentech Details
        2.6.2 Genentech Major Business
        2.6.3 Genentech DNA Repair Drugs Product and Services
        2.6.4 Genentech DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Georgetown University
        2.7.1 Georgetown University Details
        2.7.2 Georgetown University Major Business
        2.7.3 Georgetown University DNA Repair Drugs Product and Services
        2.7.4 Georgetown University DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 German Breast Group
        2.8.1 German Breast Group Details
        2.8.2 German Breast Group Major Business
        2.8.3 German Breast Group DNA Repair Drugs Product and Services
        2.8.4 German Breast Group DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 GlaxoSmithKline
        2.9.1 GlaxoSmithKline Details
        2.9.2 GlaxoSmithKline Major Business
        2.9.3 GlaxoSmithKline DNA Repair Drugs Product and Services
        2.9.4 GlaxoSmithKline DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Jiangsu Hengrui Medicine
        2.10.1 Jiangsu Hengrui Medicine Details
        2.10.2 Jiangsu Hengrui Medicine Major Business
        2.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Product and Services
        2.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Johnson & Johnson
        2.11.1 Johnson & Johnson Details
        2.11.2 Johnson & Johnson Major Business
        2.11.3 Johnson & Johnson DNA Repair Drugs Product and Services
        2.11.4 Johnson & Johnson DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Jonsson Comprehensive Cancer Center
        2.12.1 Jonsson Comprehensive Cancer Center Details
        2.12.2 Jonsson Comprehensive Cancer Center Major Business
        2.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product and Services
        2.12.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 Karyopharm Therapeutics
        2.13.1 Karyopharm Therapeutics Details
        2.13.2 Karyopharm Therapeutics Major Business
        2.13.3 Karyopharm Therapeutics DNA Repair Drugs Product and Services
        2.13.4 Karyopharm Therapeutics DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 KuDOS Pharmaceuticals
        2.14.1 KuDOS Pharmaceuticals Details
        2.14.2 KuDOS Pharmaceuticals Major Business
        2.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Product and Services
        2.14.4 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.15 National Health Service
        2.15.1 National Health Service Details
        2.15.2 National Health Service Major Business
        2.15.3 National Health Service DNA Repair Drugs Product and Services
        2.15.4 National Health Service DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.16 National Institutes of Health
        2.16.1 National Institutes of Health Details
        2.16.2 National Institutes of Health Major Business
        2.16.3 National Institutes of Health DNA Repair Drugs Product and Services
        2.16.4 National Institutes of Health DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.17 Tesaro
        2.17.1 Tesaro Details
        2.17.2 Tesaro Major Business
        2.17.3 Tesaro DNA Repair Drugs Product and Services
        2.17.4 Tesaro DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 DNA Repair Drugs Breakdown Data by Manufacturer
    3.1 Global DNA Repair Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global DNA Repair Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in DNA Repair Drugs
    3.4 Market Concentration Rate
        3.4.1 Top 3 DNA Repair Drugs Manufacturer Market Share in 2021
        3.4.2 Top 6 DNA Repair Drugs Manufacturer Market Share in 2021
    3.5 Global DNA Repair Drugs Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and DNA Repair Drugs Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global DNA Repair Drugs Market Size by Region
        4.1.1 Global DNA Repair Drugs Sales in Volume by Region (2017-2028)
        4.1.2 Global DNA Repair Drugs Revenue by Region (2017-2028)
    4.2 North America DNA Repair Drugs Revenue (2017-2028)
    4.3 Europe DNA Repair Drugs Revenue (2017-2028)
    4.4 Asia-Pacific DNA Repair Drugs Revenue (2017-2028)
    4.5 South America DNA Repair Drugs Revenue (2017-2028)
    4.6 Middle East and Africa DNA Repair Drugs Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global DNA Repair Drugs Sales in Volume by Type (2017-2028)
    5.2 Global DNA Repair Drugs Revenue by Type (2017-2028)
    5.3 Global DNA Repair Drugs Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global DNA Repair Drugs Sales in Volume by Application (2017-2028)
    6.2 Global DNA Repair Drugs Revenue by Application (2017-2028)
    6.3 Global DNA Repair Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America DNA Repair Drugs Sales by Type (2017-2028)
    7.2 North America DNA Repair Drugs Sales by Application (2017-2028)
    7.3 North America DNA Repair Drugs Market Size by Country
        7.3.1 North America DNA Repair Drugs Sales in Volume by Country (2017-2028)
        7.3.2 North America DNA Repair Drugs Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe DNA Repair Drugs Sales by Type (2017-2028)
    8.2 Europe DNA Repair Drugs Sales by Application (2017-2028)
    8.3 Europe DNA Repair Drugs Market Size by Country
        8.3.1 Europe DNA Repair Drugs Sales in Volume by Country (2017-2028)
        8.3.2 Europe DNA Repair Drugs Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific DNA Repair Drugs Sales by Type (2017-2028)
    9.2 Asia-Pacific DNA Repair Drugs Sales by Application (2017-2028)
    9.3 Asia-Pacific DNA Repair Drugs Market Size by Region
        9.3.1 Asia-Pacific DNA Repair Drugs Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific DNA Repair Drugs Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America DNA Repair Drugs Sales by Type (2017-2028)
    10.2 South America DNA Repair Drugs Sales by Application (2017-2028)
    10.3 South America DNA Repair Drugs Market Size by Country
        10.3.1 South America DNA Repair Drugs Sales in Volume by Country (2017-2028)
        10.3.2 South America DNA Repair Drugs Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa DNA Repair Drugs Sales by Type (2017-2028)
    11.2 Middle East & Africa DNA Repair Drugs Sales by Application (2017-2028)
    11.3 Middle East & Africa DNA Repair Drugs Market Size by Country
        11.3.1 Middle East & Africa DNA Repair Drugs Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa DNA Repair Drugs Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of DNA Repair Drugs and Key Manufacturers
    12.2 Manufacturing Costs Percentage of DNA Repair Drugs
    12.3 DNA Repair Drugs Production Process
    12.4 DNA Repair Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 DNA Repair Drugs Typical Distributors
    13.3 DNA Repair Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global DNA Repair Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?